SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,389,000 | +104.6% | 16,266 | +35.6% | 0.07% | +111.4% |
| Q4 2018 | $679,000 | -72.9% | 12,000 | -68.2% | 0.04% | -32.7% |
| Q2 2018 | $2,502,000 | +80.6% | 37,700 | +45.6% | 0.05% | +160.0% |
| Q4 2017 | $1,385,000 | -70.3% | 25,900 | -70.7% | 0.02% | -83.1% |
| Q4 2016 | $4,670,000 | +1097.4% | 88,500 | +917.2% | 0.12% | +391.7% |
| Q4 2015 | $390,000 | -65.9% | 8,700 | -70.7% | 0.02% | -72.1% |
| Q3 2015 | $1,145,000 | +175.2% | 29,700 | +245.3% | 0.09% | +36.5% |
| Q2 2015 | $416,000 | -53.2% | 8,600 | -55.9% | 0.06% | +50.0% |
| Q1 2014 | $888,000 | +62.3% | 19,500 | +56.0% | 0.04% | -14.3% |
| Q3 2013 | $547,000 | +47.4% | 12,500 | +5.9% | 0.05% | -24.6% |
| Q2 2013 | $371,000 | – | 11,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |